04:19 PM EST, 02/19/2025 (MT Newswires) -- Exact Sciences ( EXAS ) reported a Q4 net loss late Wednesday of $4.67 per diluted share, compared with a loss of $0.27 a year earlier.

Analysts polled by FactSet expected a loss of $0.31.

Revenue for the quarter that ended Dec. 31 was $713.4 million, up from $646.9 million a year earlier.

Analysts surveyed by FactSet expected $701.9 million.

The company expects full-year 2025 revenue of $3.03 billion to $3.09 billion. Analysts polled by FactSet expect $3.06 billion.